MedPath

Testing Hypersensitivity to Metals in Sarcoidosis Patients by Applying the MELISA Test.

Not Applicable
Conditions
Sarcoidosis
Registration Number
NCT01809145
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

The purpose of this study is to apply the MELISA test, that diagnose hypersensitivity to metals, in Sarcoidosis patients with occupational exposure.

Detailed Description

Peripheral blood from sarcoidosis patients with occupational anamnesis that involves exposure to metals will be sent to MELISA Medica in Stockholm Sweden. The MELISA test will examine hypersensitivity to metals that can be related to the granulomatous response of sarcoidosis.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria

Biopsy confirmed sarcoidosis Granulomatous disease Occupational anamnesis with exposure to metals

Exclusion Criteria

Patients with interstitial disease No occupational anamnesis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
MELISA test30 days

Using the MELISA test in peripheral blood, in order to find hypersensitivity to metals that can be related to the granulomatous response of sarcoidosis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tel-Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

Tel-Aviv Sourasky Medical Center
🇮🇱Tel Aviv, Israel
Elizabeth Fireman, PhD
Contact
972-36973988
fireman@tlvmc.gov.il
Yifat Alcalay, PhD
Contact
973-36973749
yifatal@tlvmc.gov.il

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.